With the assistance of univariate analysis, we found out that PD-L1 expression status was associated with relapse time of luminal NMIBC in the group of bladder cancer without previous frontline intervention, and it was also associated with RFS in the group of patients with luminal relapsed bladder cancer previously utilized frontline therapy by BCG instillations (Table 1). Here, CD274 is linked to urinary bladder cancer.